From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126481 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Landon L Moore und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Hauptthemen laut MEDLINE: Doublecortin-Like Kinases, MicroRNAs, Protein Serine-Threonine Kinases, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VA Merit Review, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Chronic liver diseases, fibrosis, cirrhosis, and HCC are often a consequence of persistent inflammation. However, the transition mechanisms from a normal liver to fibrosis, then cirrhosis, and further to HCC are not well understood. This study focused on the role of the tumor stem cell protein doublecortin-like kinase 1 (DCLK1) in the modulation of molecular factors in fibrosis, cirrhosis, or HCC. Serum samples from patients with hepatic fibrosis, cirrhosis, and HCC were analyzed via ELISA or NextGen sequencing and were compared with control samples. Differentially expressed (DE) microRNAs (miRNA) identified from these patient sera were correlated with DCLK1 expression. We observed elevated serum DCLK1 levels in fibrosis, cirrhosis, and HCC patients; however, TGF-β levels were only elevated in fibrosis and cirrhosis. While DE miRNAs were identified for all three disease states, miR-12136 was elevated in fibrosis but was significantly increased further in cirrhosis. Additionally, miR-1246 and miR-184 were upregulated when DCLK1 was high, while miR-206 was downregulated. This work distinguishes DCLK1 and miRNAs’ potential role in different axes promoting inflammation to tumor progression and may serve to identify biomarkers for tracking the progression from pre-neoplastic states to HCC in chronic liver disease patients as well as provide targets for treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
- Department of Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA.
- Department of Natural Sciences, Langston University, Langston, OK 73050, USA.
- Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
ORCID-Profile: Landon L Moore, Dongfeng Qu, Kamille Pitts, Nasya Cooper, Kai Ding, Michael Bronze, Courtney W Houchen
Förderung
- VA Merit Review
- U.S. Department of Veterans Affairs
Zitieren
APA
Moore, L. L., Qu, D., Sureban, S., Mitchell, S., Pitts, K., Cooper, N., Fazili, J., Harty, R., Oseini, A., Ding, K., Bronze, M., & Houchen, C. W. (2024). From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126481
Vancouver
Moore LL, Qu D, Sureban S, Mitchell S, Pitts K, Cooper N, et al. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126481
BibTeX
@article{Moore2024,
author = {Moore, Landon L and Qu, Dongfeng and Sureban, Sripathi and Mitchell, Stephanie and Pitts, Kamille and Cooper, Nasya and Fazili, Javid and Harty, Richard and Oseini, Abdul and Ding, Kai and Bronze, Michael and Houchen, Courtney W},
title = {From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126481}
}
EUVIMED